Virtus ETF Advisers’s Pfizer PFE Stock Holding History

Virtus ETF Advisers’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$626K	Sell	25,991 -134	-0.5%	-$3.5K	0.24%	110
2026 Q1	$734K	Sell	26,125 -1,986	-7%	-$52.9K	0.34%	65
2025 Q4	$700K	Buy	+28,111	New	+$709K	0.33%	73
2023 Q2	–	Sell	-19,730	Closed	-$805K	–	470
2023 Q1	$805K	Buy	19,730 +2,542	+15%	+$110K	0.44%	105
2022 Q4	$881K	Buy	17,188 +3,897	+29%	+$187K	0.46%	29
2022 Q3	$582K	Sell	13,291 -2,034	-13%	-$98.8K	0.23%	185
2022 Q2	$803K	Buy	+15,325	New	+$781K	0.3%	93
2020 Q3	–	Sell	-534	Closed	-$17K	–	408
2020 Q2	$17K	Sell	534 -131	-20%	-$4.45K	0.01%	392
2020 Q1	$21K	Sell	665 -16	-2%	-$545	0.01%	327
2019 Q4	$25K	Buy	681 +149	+28%	+$5.31K	﹤0.01%	336
2019 Q3	$18K	Hold	532	–	–	﹤0.01%	366
2019 Q2	$22K	Buy	+532	New	+$21.1K	﹤0.01%	357
2019 Q1	–	Sell	-532	Closed	-$22K	–	238
2018 Q4	$22K	Buy	+532	New	+$22.1K	﹤0.01%	221
2018 Q3	–	Sell	-1,076	Closed	-$37K	–	362
2018 Q2	$37K	Hold	1,076	–	–	0.03%	160
2018 Q1	$36K	Hold	1,076	–	–	0.03%	140
2017 Q4	$37K	Buy	+1,076	New	+$36.7K	0.05%	141

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Virtus ETF Advisers's PFE Position: Q2 2026 in Review

Virtus ETF Advisers reduced its Pfizer (PFE) stake by 0.51% in Q2 2026, selling an estimated $3.5K and leaving 25,991 shares worth $626K. The position accounts for 0.24% of the portfolio, ranked #110.

Virtus ETF Advisers first reported a position in PFE in Q4 2017 and has held it in 16 quarters since. The position peaked at $881K in Q4 2022. 2,826 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Virtus ETF Advisers held 25,991 shares of Pfizer worth $626K as of Q2 2026.
Virtus ETF Advisers sold 134 Pfizer shares in Q2 2026, an estimated $3.5K.
Pfizer made up 0.24% of Virtus ETF Advisers's portfolio in Q2 2026, its #110 holding.
Virtus ETF Advisers first reported a position in Pfizer in Q4 2017 and has held it in 16 quarters since.
Virtus ETF Advisers's Pfizer position peaked at $881K in Q4 2022.
2,826 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Virtus ETF Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.